![Lazar Dimitrov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lazar Dimitrov
Direktor/Vorstandsmitglied bei Lumos Pharma Sub, Inc.
Aktive Positionen von Lazar Dimitrov
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lazar Dimitrov
Ehemalige bekannte Positionen von Lazar Dimitrov
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Private-Equity-Analyst | 07.01.2016 | - |
Ausbildung von Lazar Dimitrov
Dartmouth College | Undergraduate Degree |
University of Washington | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Private Equity Analyst | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Finance | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
- Börse
- Insiders
- Lazar Dimitrov
- Erfahrung